other material
confidence high
sentiment positive
materiality 0.70
Alzamend Neuro, Inc. (ALZN): Nasdaq/NYSE listing notice — Alzamend Neuro regains Nasdaq minimum bid price compliance
Alzamend Neuro, Inc.
- Received Nasdaq notice on Nov 15, 2023 confirming compliance with $1.00 minimum bid price rule.
- Bid price closed at or above $1.00 for 10 consecutive trading days through Nov 13, 2023.
- Company had been at risk of delisting since January 2023; hearing extended deadline to Nov 15.
- Separate MVLS deficiency remains; Alzamend must regain compliance with $35M market value rule by March 25, 2024.
- Press release issued November 16, 2023 announcing the compliance notice.